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Introduction {#sec1}
============

Stem cells often reside in specialized microenvironments, or niches, where resident support cells, growth factors, and extracellular matrix (ECM) proteins regulate stem cell behaviors, including quiescence, proliferation, and differentiation ([@bib1]). One such niche resides in the adult ventricular zone (VZ) of the mammalian brain, consisting of adult neural stem cells (NSCs) whose apical processes are surrounded by a "pinwheel" of multiciliated ependymal cells (ECs) ([@bib18]), whose specialized cell-cell contacts help to regulate NSC functions ([@bib11], [@bib15], [@bib25]). In addition, ECM aggregates, or hubs, are localized by the ECM receptor dystroglycan at the junctions between ECs and NSCs in the apical VZ ([@bib15], [@bib33]). Beneath the EC pinwheels, in the subventricular zone (SVZ), NSC basal processes contact vascular basal lamina via α6-containing integrins ([@bib33]). Together, these and other cell-cell and cell-ECM arrangements in the ventricular-subventricular zone (V-SVZ) are thought to be critical for postnatal stem cell activation and regulated postnatal neurogenesis and gliogenesis ([@bib15], [@bib17], [@bib28], [@bib33]).

The adult V-SVZ niche emerges postnatally in rodents. Shortly after birth, radial glial cells, which serve as embryonic NSCs, begin to transition into both adult NSCs and ECs. ECs achieve a planar cell polarity whereby the basal bodies of their motile cilia polarize on their apical surfaces, which is essential for the coordinated ciliary movements that direct cerebrospinal fluid (CSF) circulation and regulate neuroblast migration ([@bib20], [@bib30]). During this time, ECs and NSCs arrange into cellular pinwheels, and diffusely distributed ECM on ECs transitions into aggregated ECM hubs at the interface of ECs and NSCs ([@bib15]).

Given the dramatic reorganization of cellular and extracellular structures that take place in the postnatal V-SVZ, we hypothesized that matrix metalloproteinases (MMPs), a family of extracellular endopeptidases, may be important in this process. The 24 mammalian MMPs are mostly secreted or membrane-tethered proteins that cleave ECM proteins, cell adhesion molecules, and growth factors ([@bib21]). Due to the wide range of substrate selectivity, their expression, secretion, and activation are tightly controlled in a cellular and developmental fashion ([@bib26]). MMPs have been shown to regulate the development and function of other stem cell niches, e.g., the hematopoietic stem cell niche and the mammary gland epithelial stem cell niche ([@bib4], [@bib8], [@bib22]). In the adult V-SVZ, MMP24 (MT5-MMP) has been found to co-localize with NSCs and control their quiescence, in both physiological and pathological states, by cleaving N-cadherin ([@bib27]). However, whether MMPs regulate the postnatal development of the V-SVZ NSC niche itself remains largely unknown.

In this study, we sought to understand how MMPs contribute to the development and function of the postnatal V-SVZ stem cell niche. We characterized MMP family expression during the NSC-to-EC transition and found MMP12 to be highly upregulated during this process, and that ECs can express an intracellular MMP12. Using an *Mmp12* mutant mouse with a selective loss of the secreted, extracellular MMP12, we explored the functions of both extracellular and intracellular MMP12 during V-SVZ niche establishment. Our study reveals that extracellular MMP12 regulates the cellular and ECM rearrangements needed to build a mature niche, whereas intracellular MMP12 has a distinct function in regulating EC ciliogenesis, with both extracellular and intracellular MMP12 forms promoting NSC quiescence and thus regulating niche output.

Results {#sec2}
=======

Identifying MMP12 as a Possible Regulator of Postnatal V-SVZ Niche Development {#sec2.1}
------------------------------------------------------------------------------

To explore a potential role for MMPs in regulating V-SVZ niche development, we applied a broad-spectrum MMP inhibitor, GM6001, to V-SVZ EC cultures (see [Figure 1](#fig1){ref-type="fig"}A), and observed a significant block in EC maturation as judged by the decrease in multiciliated (γ-tubulin^+^) cells and *FoxJ1* promoter activity ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). To determine the MMP(s) potentially responsible for this phenotype, we collected total mRNA from the EC cultures at days 1, 6, and 12 of differentiation and analyzed *Mmp* gene mRNA levels using qRT-PCR. Of the 24 *Mmps* and their splicing variants, only *Mmp2*, *11*, *12*, *14*, *15*, and *16* were highly expressed (\>5 × 10^−4^ relative to *Gapdh*). Among these, *Mmp12* was unique in being strongly upregulated during EC differentiation ([Table S1](#mmc1){ref-type="supplementary-material"} and [Figure 1](#fig1){ref-type="fig"}B). We validated the presence of MMP12 protein, both pro- (≥55 kDa) and active (22--45 kDa) forms, in western blots of conditioned media from differentiating ECs ([Figure 1](#fig1){ref-type="fig"}C). We next examined MMP12 *in vivo* using whole-mount immunohistochemistry (IHC) ([Figure 1](#fig1){ref-type="fig"}D), and identified MMP12 immunoreactivity associated with multiciliated ECs (visualized using acetylated α-tubulin immunoreactivity) that appeared to increase during V-SVZ niche development ([Figure 1](#fig1){ref-type="fig"}E).Figure 1MMP Expression in the Developing V-SVZ Stem Cell Niche(A) Schematic of ependymal cell (EC) cultures.(B) Time course to assess mRNA levels of the most highly expressed *Mmp* family members in differentiating ECs reveals *Mmp12* is upregulated during differentiation (^∗^p \< 0.05, day 1 versus day 12, n = 3 independent experiments, one-way ANOVA with Tukey-Kramer correction).(C) MMP12 western blotting of conditioned media from ECs at differentiation days 1--3, 3--6, and 6--9 (representative blot of 3 repeats).(D) Schematic of V-SVZ whole-mount IHC.(E) Representative images of V-SVZ whole-mount IHC at P3, P8, and P60 (adult). MMP12 is associated with multiciliated ECs (acetylated tubulin, Ac-tubulin), with MMP12 levels increasing during development.(F) EC cultures treated with DMSO (vehicle) or PF-356231 (5 μM) at differentiation days 0, 2, and 4. The percentage of multiciliated ECs (CD24, EC marker co-localizing with cilia) is decreased by PF-356231 (arrowheads point to multiciliated ECs; error bars denote SEM; ^∗^p \< 0.05, t test, n = 3 independent experiments).(G) Upper: EC cultures were transduced with virus containing control shRNA (Ctrl) or *Mmp12* shRNA. Middle: lentiviral construct pLB. Lower: *Mmp12* shRNA significantly reduces the percentage of multiciliated ECs (arrowheads point to multiciliated GFP^+^ cells; error bars denote SEM; ^∗^p \< 0.05, t test, n = 3 independent experiments).Scale bars, 10 μm.

To assess MMP12 function, we used a MMP12-specific inhibitor, PF-356231, and lentivirus-delivered *Mmp12* short hairpin RNA (shRNA), to specifically target MMP12 activity and expression in EC cultures ([Figures 1](#fig1){ref-type="fig"}F, 1G, [S1](#mmc1){ref-type="supplementary-material"}C, and S1D for shRNA validation). The percentage of ECs that were multiciliated (CD24^+^, with visible cilia patches) at day 6 was significantly decreased by 5 μM PF-356231 treatment ([Figure 1](#fig1){ref-type="fig"}F). Additional scoring of multiciliated ECs using γ-tubulin immunoreactivity resulted in a similar decrease in multiciliated cells by PF-356231 (vehicle: 53.4% ± 2.8%, n = 3; PF: 27.7% ± 4.2%, n = 3; p = 0.003). EC cultures were next transduced with lentivirus co-expressing shRNA and GFP ([Figure 1](#fig1){ref-type="fig"}G and [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Here, significantly fewer multiciliated ECs (γ-tubulin^+^) were observed in lentivirus transduced cells (GFP^+^) with *Mmp12* shRNA compared with control shRNA ([Figure 1](#fig1){ref-type="fig"}G).

A Functional Intracellular MMP12 Is Expressed in *Mmp12* Mutant Ependymal Cells {#sec2.2}
-------------------------------------------------------------------------------

To further assess the function of MMP12 during V-SVZ niche development, we analyzed *Mmp12* mutant mice, B6.129X-*Mmp12*^tm1Sds^/J ([@bib36]). However, using EC cultures prepared from *Mmp12* mutant mice, we noticed MMP12 immunoreactivity in cell cortices and nuclei that was similar to that in wild-type (WT) ([Figure 2](#fig2){ref-type="fig"}A). When examining the transgenic strategy of the *Mmp12* mutant, we noted that an in-frame start codon was preserved after replacing most of exon 2 with a flipped neomycin-STOP cassette ([Figure 2](#fig2){ref-type="fig"}B, mutant gene). If expressed, this gene product could produce a protein that lacks the signal peptide but preserves most of the catalytic domain and the hemopexin repeats, and would therefore be predicted to be a functional intracellular protein ([Figure 2](#fig2){ref-type="fig"}B, mutant protein).Figure 2An Intracellular MMP12 Persists in *Mmp12* Mutant Ependymal Cells(A) IHC of *Mmp12* mutant (Mut) and wild-type (WT) EC cultures at differentiation day 12, highlighting MMP12 in the cell cortex (asterisk, overlapping with phalloidin) and nucleus (arrowheads, DAPI).(B) *Mmp12* gene and MMP12 protein domains in WT and Mut mice. Splicing variations in exon2 lead to alternative *Mmp12* transcripts in WT cells (WT isoform 2).(C) MMP12 expression in WT and Mut ECs. Left: qPCR analysis with primers targeting different *Mmp12* exons. Note the high levels of *Mmp12* mRNA in Mut ECs only from primers targeting downstream exons (WT, n = 5; Mut, n = 6; 5 independent experiments; ^∗^p \< 0.05, ^∗∗^p \< 0.01, t test). Middle: western blots of cell lysates to detect intracellular MMP12 (icMMP12). An ∼40-kDa band is detected in Mut. Right: western blots of conditioned media to detect extracellular MMP12. No MMP12 is detected in Mut.(D) Western blots of HEK293T cells transfected with constructs containing full-length or icMMP12 cDNA. Left: cell lysates. Right: conditioned media. Note that full-length and icMMP12 show similar patterns (arrowheads) as WT and Mut, respectively, in (C).(E) MMP12 expression in WT and Mut lung fibroblast cells. Left: qRT-PCR. *Mmp12* transcript is diminished at all tested exons (n = 3 independent experiments, ^∗∗∗^p \< 0.001, t test). Right: western blots of cell lysates. No 40-kDa band is detected in Mut, as compared with (C).(F) Confocal images of GFP IHC in HEK293T cells transfected with GFP-icMMP12 or βDAGΔNLS-EGFP. In contrast to βDAGΔNLS-EGFP, GFP-icMMP12 co-localizes with DAPI-stained nuclear DNA. Arrowheads indicate that DAPI^−^ areas are also negative for GFP-icMMP12. GFP-icMMP12 also co-localizes with phalloidin at filopodia (arrows).(G) MMP12 enzymatic activity assay on purified full-length or mutant icMMP12 catalytic domain proteins. Both proteins when incubated with FRET peptide substrate upregulated 480/530 nm fluorescent signal, compared with 50 mM EDTA-treated negative control or PBS (full-length catalytic domain, n = 3; icMMP12 catalytic domain, n = 4; full-length or icMMP12 + EDTA, n = 3; PBS, n = 5; 3 independent experiments, one-way ANOVA with Tukey-Kramer correction; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001).(H) Streptavidin-agarose pull-down assay on HEK293T cells transfected with full-length MMP12 and icMMP12. Both full-length-MMP12 and icMMP12 were pulled down with a 5′ biotinylated DNA 50mer known to bind MMP12 (representative blot for 3 independent experiments).Error bars denote SEM. Scale bars, 10 μm.

While MMPs are conventionally known as extracellular proteins, intracellular functions were recently discovered in many MMPs (e.g., MMPs 2, 9, 12, and 14) ([@bib5], [@bib7], [@bib13], [@bib14], [@bib35], [@bib40]). For MMP12 in particular, its hemopexin domain has been found to have an antibacterial function intracellularly in macrophages ([@bib5]). Furthermore, extracellular MMP12 was reported to be transported back into cells, where it enzymatically cleaves intracellular proteins as well as translocates into the nucleus and regulates transcription ([@bib14]). In addition, the NCBI Gene database describes two transcriptional variants of mouse *Mmp12* without a signal peptide sequence (NCBI Gene: [NM_001320076.1](ncbi-n:NM_001320076.1){#intref0010}, [NM_001320077.1](ncbi-n:NM_001320077.1){#intref0015}), based on RIKEN\'s functional annotation of the mammalian genome (e.g., [Figure 2](#fig2){ref-type="fig"}B, WT isoform 2). To date, the expression and function of these potential intracellular MMP12s remains uncharacterized. We used PCR primers targeting regions of the *Mmp12* gene that varied among *Mmp12* isoforms, and found a transcript consistent with *Mmp12* WT isoform 2, which is predicted to translate into an intracellular MMP12 (icMMP12, [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2D). To test whether a truncated, icMMP12-encoding mRNA is expressed in *Mmp12* mutant ECs, we used primers targeting different exons ([Figure 2](#fig2){ref-type="fig"}B, WT gene) to quantify *Mmp12* cDNA with qRT-PCR ([Figure 2](#fig2){ref-type="fig"}C). As expected exon 1-containing transcripts were significantly reduced in *Mmp12* mutant cells. In contrast, exons 4,5- and exons 7,8-containing transcripts were present in *Mmp12* mutant cells (and even upregulated compared with WT). The 5′ end of this potential mRNA in *Mmp12* mutant ECs was confirmed with 5′ RACE (rapid amplification of cDNA ends), with the predicted ATG being the only possible in-frame start codon ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F).

To determine whether icMMP12-encoding mRNA was translated into protein, we used cell lysates (to detect intracellular MMP12) and conditioned media (to detect extracellular MMP12) from WT and *Mmp12* mutant EC cultures for western blotting. Full-length MMP12 is a 55-kDa protein. Typically, the pro-domain at the N terminus is first cleaved off to generate a 45-kDa active enzyme, then processed on both N and C termini, producing several intermediate products as well as a mature 25-kDa protein, presumably consisting only of the catalytic domain (illustrated in [Figure 2](#fig2){ref-type="fig"}B) ([@bib31], [@bib32]) (TopFIND: P34960). In WT cell lysates, we found that full-length MMP12 can be detected as a 45-kDa activated protein band, a few intermediate bands, and an ∼25-kDa mature band, which is consistent with the known protein band pattern for MMP12 ([Figure 2](#fig2){ref-type="fig"}C). Furthermore, the \>55-kDa species observed in conditioned media cannot be detected in cell lysates (for an example of an entire blot see [Figure S1](#mmc1){ref-type="supplementary-material"}C). On the other hand, in *Mmp12* mutant lysates, an ∼40-kDa band was observed ([Figure 2](#fig2){ref-type="fig"}C), indicating the presence of the mutant icMMP12 predicted by mRNA analysis. Conditioned media from WT cells contained a \>50-kDa band and an ∼25-kDa band ([Figure 2](#fig2){ref-type="fig"}C). In contrast, the conditioned media from *Mmp12* mutant cells lack any detectable MMP12 ([Figure 2](#fig2){ref-type="fig"}C), consistent with a complete loss of secreted MMP12, as reported by [@bib36].

To validate that the bands observed in *Mmp12* mutant lysates were indeed MMP12 proteins, we made expression constructs of full-length and truncated *Mmp12*, each preserving their native Kozak sequence. HEK293T cell lysates expressing the full-length or truncated recombinant MMP12s showed banding patterns similar to those of lysates from WT and *Mmp12* mutant EC cultures, respectively ([Figure 2](#fig2){ref-type="fig"}D, cell lysate). Consistent with EC cultures, only full-length *Mmp12* cDNA expressed secreted MMP12 ([Figure 2](#fig2){ref-type="fig"}D). Based on 5′ RACE ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F) and western blotting ([Figures 2](#fig2){ref-type="fig"}C and 2D), we inferred that translation of the icMMP12 in *Mmp12* mutant ECs starts from the predicted ATG site.

The B6.129X-*Mmp12*^tm1Sds^/J mouse line had been used as a complete *Mmp12* knockout, with no intracellular MMP12 being reported ([@bib5], [@bib7], [@bib36]); therefore, we sought to determine whether mutant icMMP12 was found in other cells. In lung fibroblasts, which express high levels of MMP12, we found that, unlike ECs, all primer sets detected diminished levels of *Mmp12* cDNA in *Mmp12* mutant lung fibroblasts ([Figure 2](#fig2){ref-type="fig"}E). In WT lung fibroblasts the predominant MMP12 protein was ∼55 kDa ([Figure 2](#fig2){ref-type="fig"}E), similar to what was detected in conditioned media from full-length *Mmp12* cDNA, with no detectable 40-kDa band as found in ECs ([Figure 2](#fig2){ref-type="fig"}C).

To assess mutant icMMP12 subcellular localization, we cloned *icMmp12* cDNA into pEGFP-C1 and transfected HEK293T cells ([Figure 2](#fig2){ref-type="fig"}F). GFP immunocytochemistry indicated that GFP-icMMP12 was cytosolic and nuclear. Nuclear icMMP12 co-localized with DAPI, consistent with previous observations that MMP12 can enter the nucleus and associate with DNA ([@bib14]). As a negative control, we transfected pEGFPN1-βDAGΔNLS whose protein product is excluded from the nucleus ([Figure 2](#fig2){ref-type="fig"}F). We also transfected GFP-icMMP12 into both the V-SVZ (using neonatal ventricle electroporation) and EC cultures, and detected nuclear immunoreactivity in V-SVZ cells ([Figures S2](#mmc1){ref-type="supplementary-material"}G and S2H).

Given that the mutant icMMP12 catalytic domain is slightly truncated, we wanted to confirm its biological activities. To test for enzymatic activity, we transfected 293T cells with full-length or icMMP12 catalytic domain tethered with a C-terminal 7xHis tag (pCDNA3.1^+^-*FLMmp12*Cat-7His, pCDNA3.1^+^-*icMmp12*Cat-7His) and prepared recombinant protein with Ni-nitrilotriacetic acid agarose beads under native conditions. Using an MMP12-specific enzymatic activity assay, full-length MMP12 and icMMP12 were both found to be enzymatically active ([Figure 2](#fig2){ref-type="fig"}G). Streptavidin-agarose pull-down assays were performed to assess DNA-binding ability ([Figure 2](#fig2){ref-type="fig"}H). After co-transfecting HEK293T cells with pEF1-mmp12-V5His and pMAX-GFP, or, with pEF1-icmmp12-V5His and pMAX-GFP, we incubated cell lysates with a 5′-biotinylated DNA oligo described to bind to MMP12 ([@bib14]). Streptavidin-agarose beads pulled down both full-length (45 kDa) and icMMP12 (40 kDa), but not co-transfected GFP, suggesting that icMMP12 retains DNA-binding activity.

Extracellular MMP12 Regulates V-SVZ Neural Stem Cell Niche Pinwheel Organization {#sec2.3}
--------------------------------------------------------------------------------

Given that *Mmp12* mutant ECs retain a functional icMMP12, we were able to use this mouse to explore the functions of extracellular MMP12 in postnatal V-SVZ development ([Figure 3](#fig3){ref-type="fig"}A). We focused our analysis within the anterior-dorsal V-SVZ as it contains the most typical ECs and pinwheels ([Figure 3](#fig3){ref-type="fig"}B), performing whole-mount IHC on WT and *Mmp12* mutant mice with β-catenin antibodies to label cell junctions and γ-tubulin antibodies to label ciliary basal bodies ([Figure 3](#fig3){ref-type="fig"}C). NSCs were defined by their small apical surface area and single cilium basal body, and ECs by their larger apical surface area and patches of ciliary basal bodies. At postnatal day 7 (P7) the *Mmp12* mutant V-SVZ had more NSCs per area than in WT ([Figure 3](#fig3){ref-type="fig"}D, top left), as well as more NSCs per pinwheel in P7 and adult (8-week) mice, although overall pinwheel sizes were not affected ([Figure 3](#fig3){ref-type="fig"}D, middle and bottom). In contrast, the adult *Mmp12* mutant V-SVZ contained slightly more ECs ([Figure 3](#fig3){ref-type="fig"}D, top right), although the number of ECs per pinwheel were not significantly affected ([Figure 3](#fig3){ref-type="fig"}D, middle right). Considering V-SVZ regional heterogeneities, we also examined the anterior-ventral (AV) and posterior-dorsal (PD) V-SVZ, areas known to contain niche pinwheels ([@bib37]). We found similar increases in NSCs per pinwheel and NSCs per area in the AV, but not PD, V-SVZ ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Together, these results indicate that the lack of *extracellular* MMP12 leads to disturbances in V-SVZ niche pinwheel organization in the anterior V-SVZ, although EC maturation appears to proceed with relative normality.Figure 3Extracellular MMP12 Regulates V-SVZ Niche Cellular and ECM Organization(A) The presence or absence of extracellular and intracellular MMP12s in WT and *Mmp12* mutant (Mut) cells.(B) V-SVZ areas analyzed in this study. Left: whole-mount V-SVZ. Right: an anterior brain coronal section. AD, anterior dorsal; AV, anterior ventral; PD, posterior dorsal; PV, posterior ventral.(C) Representative images of WT and Mut whole-mount IHC to indicate cell junctions (β-catenin) and ciliary basal bodies (γ-tubulin). Neural stem cell (NSC) clusters are highlighted in yellow.(D) Quantification of NSCs, ECs, and pinwheels. NSCs/area at P7, multiciliated ECs/area at adult, and NSCs/pinwheel at P7 and adult are increased in Mut (P7 WT, n = 6 mice; P7 Mut, n = 6 mice; adult WT, n = 4 mice; adult Mut, n = 3 mice; ^∗^p \< 0.05, t test).(E) Representative images of WT and Mut whole-mount IHC to indicate cell junctions (β-catenin) and ECM hubs (laminin). Adult ECM hubs are often abnormal in size in Mut (arrowheads) (^∗^p \< 0.05, t test).(F) The percentage of ECs with ECM at P7 and the ECM hubs per area in adults are both lower in Mut V-SVZ (^∗^p \< 0.05, t test; P7 WT, n = 4 mice; Mut, n = 4 mice; adult WT, n = 5 mice; Mut, n = 6 mice). In adults, Mut hub size distribution is different than in WT (^∗∗^p \< 0.01 by Kolmogorov-Smirnov test; P7 WT, n = 674 hubs; Mut, n = 273, from 4 mice each; adult WT, n = 883, 5 mice; Mut, n = 587, 6 mice).(G) Mut EC cultures at differentiation day 12 have a significantly lower level of laminin (WT, n = 4; Mut, n = 3; 3 independent experiments; ^∗^p \< 0.05, t test).Error bars denote SEM. Scale bars, 10 μm.

To determine whether extracellular MMP12-regulated ECM hubs, aggregated ECM structures near the ventricle surface ([@bib15]), we performed whole-mount IHC with a polyclonal laminin-111 antibody that detects the majority of laminin subtypes. At P7 ECM hubs were not fully formed, so we measured the percentage of ECs with ECM aggregates ([Figure 3](#fig3){ref-type="fig"}E, asterisk), while in the adult V-SVZ we assessed ECM hub density and ECM hub size. We found that *Mmp12* mutants had significantly fewer ECM-associated ECs at P7 and fewer ECM hubs per area in adulthood ([Figure 3](#fig3){ref-type="fig"}F, top). Although the mean ECM hub sizes were similar in WT and *Mmp12* mutant ([Figure 3](#fig3){ref-type="fig"}F, middle), ECM hubs in *Mmp12* mutants had altered size distributions, with fewer medium-sized hubs and more abnormally large ones ([Figure 3](#fig3){ref-type="fig"}E, arrowhead; [Figure 3](#fig3){ref-type="fig"}F, bottom, arrowheads). *Mmp12* mutant EC cultures had less laminin protein ([Figure 3](#fig3){ref-type="fig"}G); however, no obvious changes in laminin cleavage products were observed in cell lysates (not shown). Together these data indicate an aberrant V-SVZ ECM in mice that lack extracellular MMP12.

Since laminin can be a substrate of MMP12, it was surprising that eliminating extracellular MMP12 would lead to *less* laminin. As all laminin subunit mRNA transcripts were at normal levels in *Mmp12* mutant ECs (not shown), MMP12 likely regulates laminin at the post-transcriptional level. One possibility is an upregulation of other MMPs or downregulation of TIMPs (tissue inhibitors of metalloproteinases), leading to enhanced laminin digestion. Out of all the *Mmps* and *Timps*, we found that only *Mmp2* mRNA levels were modestly upregulated in *Mmp12* mutant EC cultures ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4C). However, we detected similar levels of the MMP2 pro-enzyme and no activated MMP2 protein from either WT or *Mmp12* mutant cells by gelatin zymography ([Figure S4](#mmc1){ref-type="supplementary-material"}B) We also found no change in protein levels of β-dystroglycan and α6-integrin, two laminin receptors whose loss could affect cell association with laminin, and no change in mRNA levels of β1 and β4, the integrin β subunits that associate with α6 ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

Extracellular MMP12 Regulates Translational Planar Cell Polarity of V-SVZ ECs {#sec2.4}
-----------------------------------------------------------------------------

To determine whether extracellular MMP12 regulates V-SVZ translational planar cell polarity, we analyzed whole mounts for basal body patch displacement and angle distribution ([Figure 4](#fig4){ref-type="fig"}A), as described by [@bib20]. We found that V-SVZ translational polarity was disturbed in both P7 ([Figures 4](#fig4){ref-type="fig"}B and 4D \[left\]) and adult *Mmp12* mutant mice ([Figures 4](#fig4){ref-type="fig"}C and 4E \[left\]). Basal body patches were less displaced in *Mmp12* mutants at P7 ([Figure 4](#fig4){ref-type="fig"}D, right), indicative of decreased EC maturity, but more displaced in adults ([Figure 4](#fig4){ref-type="fig"}E, right). The abnormality in patch displacement was not a result of alterations of basal body patch sizes (P7: WT = 29.61 ± 1.45 μm^2^, n = 4 mice; Mut = 30.54 ± 1.76 μm^2^, n = 5; p = 0.68; adult: WT = 35.47 ± 1.59 μm^2^, n = 4; Mut = 33.26 ± 0.57 μm^2^, n = 3; p = 0.30). The AV and PD V-SVZ of P7 *Mmp12* mutant mice also had dispersed patch angle distributions, but no significant changes in patch displacement ([Figure S3](#mmc1){ref-type="supplementary-material"}C).Figure 4Extracellular MMP12 Regulates EC Translational Planar Cell Polarity(A) Planar cell polarity analysis. Cell boundaries (red) and ciliary basal body (green) patches were traced to calculate their respective centers (yellow). The distance between the centers (a) and distance between cell center and cell border (b) are used to calculate basal body patch displacement (a/b). The distribution of line angles (θ) throughout the field was measured.(B and C) Representative images of WT and *Mmp12* mutant (Mut) whole-mount IHC (upper) and tracings (lower) at P7 (B) and adult (C). Arrows indicate displacement of basal body patches from cell centers.(D and E) Quantification of θ distribution and patch displacement. θ distributions are disrupted in Mut at P7 and adult (^∗∗∗^p \< 0.001, Watson\'s U^2^). Mut patch displacements are decreased at P7 (^∗^p \< 0.05, t test) and increased in adults (^∗∗∗^p \< 0.001, t test). Four or more mice were analyzed in each group. Cells traced: P7 WT, n = 571 cells; P7 Mut, n = 1,354; adult WT, n = 960; adult Mut, n = 814.Error bars denote SEM. Scale bars, 10 μm.

Intracellular MMP12 Promotes Ependymal Ciliogenesis via FOXJ1 {#sec2.5}
-------------------------------------------------------------

In contrast to MMP12 pharmacological inhibition or *Mmp12* shRNA knockdown with which EC ciliogenesis was inhibited ([Figures 1](#fig1){ref-type="fig"}F and 1G), *Mmp12* mutant mice, which serve as an extracellular MMP12 knockout, had normal EC ciliogenesis both *in vivo* ([Figures 3](#fig3){ref-type="fig"}C and 3D) and *in vitro* (not shown). Because the MMP12 inhibitor PF-356231 and *Mmp12* shRNA are predicted to suppress both extracellular and intracellular MMP12, we hypothesized that the ciliogenic defects in these experiments could reflect separate functions of intracellular MMP12 (icMMP12). To manipulate potential icMMP12 expression in the developing V-SVZ, we used neonatal ventricle electroporation to introduce plasmids to the V-SVZ at P1 followed by an analysis of EC ciliogenesis ([Figure 5](#fig5){ref-type="fig"}A). First, we electroporated both WT and *Mmp12* mutant mice with an *Mmp12* shRNA plasmid co-expressing histone H2B-CFP (pH2B-CFP-SUPER), then analyzed V-SVZ whole mounts at P7 ([Figure 5](#fig5){ref-type="fig"}B). In WT mice, *Mmp12* shRNA prevents both extracellular and intracellular MMP12 expression, whereas in *Mmp12* mutant mice, *Mmp12* shRNA prevents icMMP12 expression in cells that already lack extracellular MMP12, therefore revealing potential functions of icMMP12 ([Figure 5](#fig5){ref-type="fig"}C, schematics). *Mmp12* shRNA reduced the percentage of multiciliated cells that emerged from transfected CFP^+^ VZ cells in both WT and *Mmp12* mutant mice ([Figure 5](#fig5){ref-type="fig"}C). We also found no cleaved-caspase-3^+^ cells in the EC layer, indicating that cell death is unlikely to be contributing to the decrease in mature ECs ([Figure S5](#mmc1){ref-type="supplementary-material"}A). If icMMP12 is required for ciliogenesis, then a prediction is that overexpressing icMMP12 may promote ciliogenesis. We therefore electroporated an icMMP12 construct into P1 WT mice ([Figure 5](#fig5){ref-type="fig"}D), and evaluated the whole mount at P5 to better catch a potential enhancement of EC ciliogenesis. Indeed, icMMP12 overexpression increased the percentage of multiciliated ECs that formed by P5 ([Figure 5](#fig5){ref-type="fig"}E). To determine whether icMMP12 affected ECM hub formation, we overexpressed icMMP12 in WT neonates through ventricle electroporation and analyzed whole mounts using laminin IHC. However, we did not observe significant changes in the percentage of ECM hub^+^ cells on the ventricular surface (control, 7.8% ± 1.1%, n = 5; icMMP12, 10.6% ± 1.8%, n = 4, p = 0.21), which suggests that icMMP12 is not instrumental for ECM hub formation.Figure 5Intracellular MMP12 Regulates EC Ciliogenesis(A) Schematic of neonatal *in vivo* electroporation.(B) *In vivo* electroporation of WT and *Mmp12* mutant (Mut) mice with scrambled shRNA or *Mmp12* shRNA.(C) Left: representative images of whole-mount IHC at P7. Arrows, multiciliated H2B-CFP^+^ cells. Arrowheads, non-multiciliated H2B-CFP^+^ cells. Right: in both WT and Mut mice, *Mmp12* shRNA significantly reduced the percentage of multiciliated H2B-CFP^+^ cells (WT, n = 4 mice; Mut, n = 3 mice; ^∗^p \< 0.05, t test).(D) *In vivo* electroporation of WT mice with *icMmp12* cDNA co-expressing GFP, followed by whole-mount IHC at P5.(E) Representative IHC images at P5. Arrows, multiciliated GFP^+^ cells. Arrowheads, non-multiciliated GFP^+^ cells. The relative percentage of multiciliated GFP^+^ cells was increased by icMMP12 overexpression (Ctrl, n = 5 mice; *icMmp12*, n = 6 mice; ^∗^p \< 0.05, t test).(F) Same experimental scheme as in (B). Upper: Representative images of FOXJ1, GFP co-IHC (arrows, FOXJ1^+^CFP^+^ cells; arrowheads, FOXJ1^−^CFP^+^ cells). Lower: The percentage of FOXJ1^+^ cells within the CFP^+^ cell population was decreased by *Mmp12* shRNA (ctrl shRNA, n = 5 mice; *Mmp12* shRNA, n = 4 mice; ^∗^p \< 0.05, t test).Error bars denote SEM. Scale bars, 10 μm.

FOXJ1 has been shown to be a master regulator of ciliogenesis in ECs as well as in other multiciliated cells ([@bib6]). As GM6001 (a pan-MMP inhibitor) blocked *FoxJ1* transcription in EC cultures ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B), we hypothesized that icMMP12 may support ciliogenesis by regulating FOXJ1 levels. To test this, we electroporated *Mmp12* mutant mice at P1 with control or *Mmp12* shRNA, as above ([Figure 5](#fig5){ref-type="fig"}B), and analyzed whole mounts at P7 to determine the percentage of FOXJ1^+^ cells within the CFP^+^ cells. We found that *Mmp12* shRNA on the background of *Mmp12* mutant mice significantly decreased the percentage of FOXJ1^+^ cells, indicating that icMMP12 regulates EC ciliogenesis at the level of, or upstream of, FOXJ1 ([Figure 5](#fig5){ref-type="fig"}F).

Extracellular and Intracellular MMP12 Both Promote Neural Stem Cell Quiescence {#sec2.6}
------------------------------------------------------------------------------

To investigate potential roles for extracellular and intracellular MMP12 in niche function, we analyzed the proliferation of NSCs (SOX2^+^MASH1^−^) and transient amplifying progenitors (TAPs, SOX2^+^Mash1^+^) in the *Mmp12* mutant and WT littermate V-SVZ ([Figure 6](#fig6){ref-type="fig"}A), as well as in the mmp12 mutant V-SVZ following either *Mmp12* or control shRNA ([Figure 6](#fig6){ref-type="fig"}E). Coronal sections were assessed by IHC for Ki67 to detect proliferating cells, and SOX2 to detect a combination of NSCs and TAPs. At P7, V-SVZ in *Mmp12* mutant mice had a higher percentage of proliferating SOX2^+^ cells than WT mice ([Figures 6](#fig6){ref-type="fig"}A and 6D \[left\]). shRNA-mediated loss of icMMP12 in the *Mmp12* mutant V-SVZ also increased proliferation ([Figures 6](#fig6){ref-type="fig"}E and 6H \[left\]). To distinguish NSCs and TAPs within the SOX2^+^ cell pool, we co-labeled Mash1, a TAP marker ([@bib10]), and Ki67, and found no changes in proliferative TAPs ([Figures 6](#fig6){ref-type="fig"}B, 6D \[middle\], 6F, and 6H \[middle\]). Finally, considering that \>90% of TAPs were proliferative, a shift in the %TAPs within the total SOX2^+^ pool could also contribute to the increase in SOX2^+^ cell proliferation. However, we found no change in the %Mash1^+^ out of the total SOX2^+^ cell pool (right-hand panels of [Figures 6](#fig6){ref-type="fig"}C, 6D, 6G, and 6H), indicating that the increase in proliferation in SOX2^+^ cells reflects increased NSC activation.Figure 6Extracellular and Intracellular MMP12 Both Suppress NSC Proliferation(A--C) IHC in coronal sections from WT and *Mmp12* mutant (Mut) mice at P7. Arrowheads, double-positive cells; asterisks, non-specific vascular staining.(D) Quantification of (A), (B), and (C) (left to right). The %Ki67^+^ cells within the SOX2^+^ cell population is significantly increased in Mut (WT, n = 6 animals; Mut, n = 9; ^∗^p \< 0.05, t test). The %Ki67^+^ cells within MASH1^+^ cells, or the %MASH1^+^ cells within SOX2^+^ cells are not changed (WT, n = 4 mice; Mut, n = 4 mice; p \> 0.05, t test).(E--G) IHC in coronal sections from P7 Mut mice electroporated with control (Ctrl) or *Mmp12* shRNA. (E) SOX2, H2B-CFP, Ki67 co-IHC. (F) MASH1, H2B-CFP, Ki67 co-IHC. (G) MASH1, H2B-CFP, SOX2 co-IHC. Arrowheads point to triple-positive cells.(H) Quantification of (E), (F), and (G) (left to right). Within H2B-CFP^+^ cells, the percentage of SOX2^+^ cells that are Ki67^+^ is significantly increased by *Mmp12* shRNA (Ctrl shRNA, n = 3 mice; *Mmp12* shRNA, n = 3 mice; ^∗^p \< 0.05, t test). The %Ki67^+^ cells among MASH1^+^ cells or the %MASH1^+^ cells among SOX2^+^ cells are not changed by *Mmp12* knockdown (WT, n = 4 mice; Mut, n = 4 mice; p \> 0.05, t test).Error bars denote SEM. Dashed lines indicate ventricular surfaces. Scale bars, 10 μm.

*Mmp12* mutant mice (lacking extracellular MMP12) were previously reported to have delayed myelination in the absence of any change in oligodendrocyte progenitors ([@bib9]), but it remained unclear whether icMMP12 influences neurogenesis and oligodendrogenesis. We therefore introduced *Mmp12* shRNA by ventricle electroporation into *Mmp12* mutant mice and assessed neuronal (DCX^+^) and oligodendroglial (OLIG2^+^) progenitors in whole mounts. The fractions of neuronal and oligodendroglial progenitors were similar to those of *Mmp12* and control shRNAs ([Figure S5](#mmc1){ref-type="supplementary-material"}B) suggesting that icMMP12 does not affect NSC fate decisions. To determine whether MMP12 influenced rostral migration of neuroblasts, we compared the olfactory bulb (OB) in WT and *Mmp12* mutants or performed icMMP12 knockdown in the *Mmp12* mutant V-SVZ. After electroporating constructs at P1 and assessing coronal sections at P7 ([Figure S5](#mmc1){ref-type="supplementary-material"}C), we found more H2B-CFP^+^ cells in the OB when icMMP12 was silenced ([Figures S5](#mmc1){ref-type="supplementary-material"}C--S5F), indicating that icMMP12 may influence the ability of V-SVZ neuroblasts to reach their OB target.

Discussion {#sec3}
==========

We investigated the potential role of the MMP family in the development of the V-SVZ NSC niche and found that MMP12 is not only highly expressed in developing ECs but regulates EC maturation and, ultimately, V-SVZ niche output. While MMPs have been found to regulate other stem cell niches ([@bib4], [@bib8], [@bib22]), in the V-SVZ only one other MMP, MMP24 (MT5-MMP), has been linked to V-SVZ stem cell niche function, where it is enriched in adult NSC cell junctions and has been shown to regulate adult V-SVZ stem cell quiescence ([@bib27]). Since it is currently unknown whether *Mmp24* plays a role in the development of the V-SVZ NSC niche, our finding that MMP12 regulates EC and V-SVZ niche development is the first to report this role for any MMP.

Surprisingly, we found that *Mmp12* mutant ECs express a truncated yet functional intracellular MMP12 protein, which we referred to as icMMP12, whose expression may be cell type specific. We further found that the loss of the extracellular MMP12 had no effect on EC ciliogenesis, while the loss of icMMP12 attenuated EC ciliogenesis, demonstrating that icMMP12 is sufficient to support MMP12\'s role in EC ciliogenesis. Although MMPs are well known as extracellular proteases, a recent landmark study has suggested that extracellular MMP12 can be taken up by cells and then function intracellularly, both as a protease and as a transcriptional regulator ([@bib14]). In addition, two variant transcripts have been predicted to produce an intracellular-only MMP12. Indeed, we found that one of these alternative transcripts is likely to be present in WT ECs. Therefore ECs may contain a unique pool of MMP12 whose sole function is intracellular. A better understanding of the expression patterns of the different *Mmp12* isoforms, both developmentally and across different cell types, may help to reveal new insights into the putative roles of intracellular MMP12.

The distinct cellular locations of extracellular and intracellular MMP12s indicated that they may have unique functions. By comparing the V-SVZ in WT and *Mmp12* mutant mice, which solely lack the secreted, extracellular MMP12, we concluded that extracellular MMP12 regulates the development of the V-SVZ niche pinwheel organization and associated ECM. Since a main function of MMPs is as a protease that can cleave the ECM, it was surprising that *Mmp12* mutant mice had *fewer* ECM hubs and *decreased* laminin levels, in contrast to the laminin *accumulation* in alveoli previously reported in *Mmp12* mutant mice ([@bib38]). This indicates that the ECM disturbances in the V-SVZ of *Mmp12* mutant mice likely do not occur directly through altered laminin degradation by MMP12. We therefore explored the possibility that alterations in other MMPs, TIMPs, α6-containing integrins, or dystroglycan may lead to the ECM phenotypes, but found no obvious differences. This does not eliminate the possibility that other MMPs and proteases may be responsible for the altered ECM and cellular arrangements found in the *Mmp12* mutant V-SVZ, which could occur via changes in their translation, secretion, or activation state.

ECM hubs first appear in the V-SVZ at P6--P7 on surfaces of ECs and are thought to be important for regulating niche NSCs by capturing growth factors found in the CSF ([@bib16]). ECM hubs are thought to be anchored by integrin and dystroglycan ECM receptors, which may serve to initiate signaling cascades influential to NSC behavior ([@bib15], [@bib33]). While the mechanism by which ECM hubs are produced and organized remains unknown, possible mechanisms include spatially targeted ECM deposition or clearance, or aggregating/relocating existing ECM. While ECM hubs appear to form while associated with ECs, VZ microglia may also contribute to hub development, as VZ microglia express several ECM proteins and proteases including MMP12 ([@bib34]). The discovery that MMP12 regulates VZ ECM hubs may help to shed light on the mechanism(s) by which ECM hub development proceeds.

While *Mmp12* mutant mice have disturbances in the translational planar cell polarity of VZ ECs, ciliogenesis itself remained unchanged. Yet, surprisingly, inhibiting MMP12 activity with a membrane permeable compound caused ciliogenic defects in EC cultures, suggesting that icMMP12 is involved in ciliogenesis. We performed shRNA knockdown or overexpression of icmmp12 *in vivo* to test this hypothesis, and furthermore found that icMMP12 regulates EC ciliogenesis through FOXJ1, a transcription factor required for multiciliogenesis ([@bib6]). As MMP12 has been reported to act both as an intracellular protease and transcription regulator, it will be interesting to determine whether icMMP12 regulates FOXJ1 levels through its proteolytic activities or through a transcriptional-modulatory mechanism.

Stem cell niches and their support cells tightly control stem cell behaviors ([@bib12]). In the current study, we found that either selective loss of extracellular MMP12 (comparing WT with *Mmp12* mutants) or loss of icMMP12 via knockdown strategies led to a significant upregulation of NSC proliferation. As *Mmp12* mRNA was virtually non-detectable in NSCs *in vitro*, we inferred that enhanced NSC proliferation in response to MMP12 loss was most likely an indirect consequence of disturbed niche support cells. For example, secreted MMP12 originating from ECs may normally influence surface proteins on NSCs, or translocate into NSCs to regulate NSC activation state. Consequently, loss of extracellular MMP12, originating from ECs, could affect NSC proliferation by disturbing NSC-intrinsic mechanisms. On the other hand, changes in NSC proliferation seen following the loss icMMP12 in the *Mmp12* mutant V-SVZ, may occur due to dysregulated timing of EC differentiation that in conjunction alters the activation dynamics of the postnatal NSC pool. Recent evidence indicates that adult neurogenesis is important in neuron-circuit plasticity ([@bib23]) and is required for olfactory-dependent behaviors ([@bib3], [@bib29]). As increased NSC proliferation may lead to early depletion of the NSC pool, it will be important to investigate how MMP12 can affect the aging V-SVZ and related neuron-circuit homeostasis.

The early postnatal V-SVZ undergoes complex organizational changes in a short span of time to generate the adult NSC niche, in a process that is only partly understood. This study demonstrates that MMP12 is involved in multiple aspects of V-SVZ niche development, leading to changes in this stem cell niche\'s function, and additionally reveals a unique function of intracellular MMP12 in EC maturation. These discoveries provide new insight into how MMPs can act to sculpt both the form and function of developing stem cell niches, with implications for homeostasis in adult and aging brains.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Mice were housed and cared for according to NIH and IACUC guidelines. C57/bl6 mice and mutant mice of C57/bl6 background (B6.129X-*Mmp12*^tm1Sds^/J) ([@bib36]) were from The Jackson Laboratory. *FoxJ1*-promoter GFP-transgenic mice were a gift from Dr. Ken-Ichi Takemaru ([@bib24]).

Image Acquisition and Analysis {#sec4.2}
------------------------------

Confocal images were acquired from Zeiss LSM510 or LeicaSP8X confocal laser-scanning microscopes. Selected fluorescent images for cell culture were acquired using a Zeiss Axiovert 200M epifluorescent microscope. Image analysis was done with Fiji software, and data processing for planar cell polarity was done with MATLAB software ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Statistical Analysis {#sec4.3}
--------------------

Statistical analyses (one-way ANOVA followed by multiple comparisons with Tukey-Kramer corrections, Watson\'s U^2^, and Kolmogorov-Smirnov test) were performed using MATLAB. t Tests were performed with Excel. p \< 0.05 was considered statistically significant.

Antibodies and Dyes {#sec4.4}
-------------------

Please refer to [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for full details.

Primers, DNA Oligos, and Sequencing {#sec4.5}
-----------------------------------

DNA sequencing was carried out at Stony Brook Genomics Core Facility. Please refer to [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for a list of primers.

MMP12 Enzymatic Activity Assay {#sec4.6}
------------------------------

Proteolytic activity of MMP12 was analyzed with SensoLyte 520 MMP-12 assay kit. Sodium azide (0.02%) was added to all reactions to prevent microbe growth during incubation. Reactions were incubated in the dark at 37°C for 0, 1, 2, and 4 days before fluorescence reading with a Fluoroskan Ascent at excitation/emission of 480/530 nm.

Ependymal Cell Culture {#sec4.7}
----------------------

EC cultures were adapted from a previous study ([@bib25]). All media contained L-glutamine and 1% penicillin/streptomycin. Minimum essential medium with HEPES was used for dissections. DMEM with 10% fetal bovine serum (FBS) was used to stimulate cell proliferation. DMEM with 2% FBS was used to induce EC differentiation. Papain solution, containing 1.2 μg/mL papain, 0.24 mg/mL L-cysteine, and 30 μg/mL DNaseI type IV dissolved in dissection medium was activated at 37°C for 30 min followed by sterile filtration. Tissue culture dishes were coated with 5 μg/mL poly-D-lysine at room temperature for at least 1 hr before being washed twice with sterile water. Lateral ventricular walls were dissected from P0--P1 mice in dissection medium and placed in a vial with 1 mL of dissection medium. Activated papain solution (200 μL) was added to each vial and incubated at 37°C for 20 min. The reaction was stopped by adding 2 mL of proliferation media. Tissue was mechanically dissociated with a fire polished Pasteur pipet in dissection medium. Dissociated cells were then switched into proliferation medium, and cells were plated at the density of 0.08 brains/cm^2^ tissue culture surface. Cells reached confluence in 6--7 days and were switched to differentiation medium, in which cells differentiate into ECs for 6--12 days.

Whole-Mount V-SVZ Immunohistochemistry {#sec4.8}
--------------------------------------

Whole-mount V-SVZ immunohistochemistry was adapted from a previous protocol ([@bib19]). In brief, mouse brains were dissected to expose the lateral ventricular walls. The tissue was submerged in 1% paraformaldehyde (PFA) in PBS and fixed at 4°C overnight. The tissue was subject to additional fixation with pre-chilled methanol-acetone (1:1) on ice for 10 min or heat-mediated antigen retrieval in sodium acetate buffer (pH 6), depending on the target antigen. Tissue was then washed with PBS and blocked in blocking solution (PBS containing 0.1% Triton X-100, 10% donkey serum) at room temperature for 1 hr, followed by primary antibody incubation overnight at 4°C, and secondary antibody incubation at room temperature for 2 hr. Antibodies were diluted in blocking solution. After washing, tissue was stained with DAPI for 10 min, and lateral walls were further dissected and mounted on glass slides with Slowfade Gold and coverslipped.

Streptavidin-Agarose Pull-Down Assay {#sec4.9}
------------------------------------

The streptavidin-agarose pull-down assay was adapted from an existing protocol ([@bib39]). In brief, 5′ biotinylated single-stranded oligos were dissolved to 100 mM in NaCl-Tris-EDTA buffer (pH 8.0). Complementary oligos were combined at 1:1 and incubated in a thermocycler at 95°C for 5 min, followed by −1.0°C per min for 70 min. HEK293T cells were transfected with XtremeGene HP transfection reagent. After 48 hr, cells were lysed on ice in 250 μL non-denaturing lysis buffer (25 mM Tris-HCl \[pH 7.4\], 100 mM NaCl, 1% Triton X-100, 1 mM PMSF) and cleared by centrifugation. The lysates were quantified with DC protein assay and adjusted to 8 mg/mL. Streptavidin-agarose beads were blocked in 4% BSA for 1 hr and 50 μL of the beads was used to pre-clear the lysate for 0.5 hr at room temperature. Pre-cleared cell lysate (250 μL) was then combined with 750 μL of PBS 1 mM with PMSF, 0.5 nM annealed oligo, and 50 μL of streptavidin-agarose beads, and incubated with gentle rotation at room temperature for 2 hr. The beads were then washed three times with PBS with 1 mM PMSF and boiled for 3 min with 50 μL 4× LDS sample buffer with 12% 2-mercaptoethanol. The eluate (25 μL) was used for western blotting.

Neonatal Ventricle Electroporation {#sec4.10}
----------------------------------

Neonatal ventricle electroporation was adapted from a previous protocol ([@bib2]). In brief, DNA constructs were purified with EndoFree Plasmid Maxi Kit and quantified with NanoDrop to ensure concentration \>2 μg/μL, 260/230 \> 2, and 1.8 \< 260/280 \< 2. P1 mice with milk spots were anesthetized using hypothermia. A 10-μL Hamilton syringe with 32-gauge needle was used for injection of 1 μL of DNA into the left lateral ventricle, at the middle point between the left eye and the center of lambda suture, and at the depth of 2--3 mm. The heads were then held with a tweezer electrode wet with PBS and subjected to electroporation at 5 square pulses, 100 V, 50 ms per pulse with 950-ms intervals, using an ECM 830 Generator. Mice recovered on a heating pad until resuming activity before being returned to their mothers.
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